5/16
02:13 pm
pbla
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
High
Report
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/15
04:20 pm
pbla
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
High
Report
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
5/15
04:10 pm
pbla
Panbela Provides Business Update and Reports Q1 2024 Financial Results
High
Report
Panbela Provides Business Update and Reports Q1 2024 Financial Results
5/6
08:00 am
pbla
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Low
Report
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
5/1
04:15 pm
pbla
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Medium
Report
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
4/30
08:00 am
pbla
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
Low
Report
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
4/22
08:13 am
pbla
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 [Yahoo! Finance]
High
Report
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 [Yahoo! Finance]
4/22
08:00 am
pbla
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
High
Report
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
5/15/2024
04:10 pm
pbla
panbela therapeutics, inc.
MISS
Report
20.0%
panbela therapeutics, inc.
3/26/2024
04:10 pm
pbla
panbela therapeutics, inc.
MISS
Report
5.4%
panbela therapeutics, inc.
11/9/2023
04:10 pm
pbla
panbela therapeutics, inc.
MISS
Report
-0.1%
panbela therapeutics, inc.
8/10/2023
04:10 pm
pbla
panbela therapeutics, inc.
MISS
Report
-4.1%
panbela therapeutics, inc.
5/16
06:04 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/16
06:03 am
pbla
Form 424B3 Panbela Therapeutics,
High
Report
Form 424B3 Panbela Therapeutics,
5/15
04:33 pm
pbla
Form 10-Q Panbela Therapeutics, For: Mar 31
High
Report
Form 10-Q Panbela Therapeutics, For: Mar 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register